p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.

Kudahetti, Sak; Fisher, Gabrielle; Ambroisine, Laurence; Foster, Christopher; Reuter, Victor; Eastham, James; Møller, Henrik; Kattan, Michael W; Cooper, Colin S; Scardino, Peter; Cuzick, Jack; Berney, Daniel M

Kudahetti, Sak; Fisher, Gabrielle; Ambroisine, Laurence; Foster, Christopher; Reuter, Victor; Eastham, James; Møller, Henrik; Kattan, Michael W; Cooper, Colin S; Scardino, Peter; Cuzick, Jack; Berney, Daniel M.

Affiliation

Kudahetti S; The Orchid Tissue Laboratory, Barts and The London School of Medicine and Dentistry, Centre for Molecular Oncology, London.

BJU Int ; 104(1): 20-4, 2009 Jul.

Article de En | MEDLINE | ID: mdl-19239456

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Protéine p53 suppresseur de tumeur Type d'étude: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Humans / Male / Middle aged Langue: En Journal: BJU Int Sujet du journal: UROLOGIA Année: 2009 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google